US Stock MarketDetailed Quotes
WINT Windtree Therapeutics
- 8.2900
- +5.0000+151.98%
Close Jul 26 16:00 ET
- 7.6100
- -0.6800-8.20%
Post 20:01 ET
4.91MMarket Cap0.62P/E (TTM)
9.4000High6.1600Low48.57MVolume9.2100Open3.2900Pre Close374.40MTurnover9117.67%Turnover RatioLossP/E (Static)591.70KShares30.060052wk High0.32P/B4.42MFloat Cap2.810052wk Low--Dividend TTM532.75KShs Float3341518.3292Historical High--Div YieldTTM98.48%Amplitude2.8100Historical Low7.7070Avg Price1Lot Size
Windtree Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -16.99%-2.95M | 30.92%-13.44M | -5.53%-3.57M | 5.98%-3.85M | 33.49%-3.5M | 62.49%-2.52M | 17.80%-19.45M | 31.47%-3.38M | 22.38%-4.1M | 28.97%-5.26M |
| Net income from continuing operations | 348.58%10.22M | 48.25%-20.29M | 46.82%-5.15M | -9.10%-4.43M | 61.92%-6.6M | 49.42%-4.11M | 42.03%-39.21M | 25.86%-9.69M | 50.61%-4.06M | 53.64%-17.33M |
| Operating gains losses | -70,238.10%-14.73M | 101.30%9K | 11.69%258K | 64.04%-164K | 53.91%-106K | 108.90%21K | -274.49%-691K | 255.38%231K | -1,570.97%-456K | -156.23%-230K |
| Depreciation and amortization | -8.70%21K | -84.62%82K | -8.33%22K | -33.33%14K | 4.55%23K | -95.06%23K | 177.60%533K | -53.85%24K | -55.32%21K | -54.17%22K |
| Deferred tax | ---- | --0 | ---- | ---- | ---- | ---- | 86.31%-1.37M | ---- | ---- | ---- |
| Other non cash items | -12.93%101K | -22.54%409K | -9.91%100K | -12.73%96K | -27.07%97K | -33.33%116K | -54.91%528K | -35.47%111K | -34.91%110K | -19.88%133K |
| Change In working capital | 79.49%1.19M | 213.56%2.02M | 208.29%901K | 134.93%320K | 150.19%134K | 178.57%663K | -2,963.79%-1.78M | -231.02%-832K | -186.74%-916K | 83.51%-267K |
| -Change in prepaid assets | 23.85%270K | -14.22%923K | 23.39%480K | 62.83%311K | -133.46%-86K | -8.79%218K | -21.17%1.08M | -43.05%389K | -62.03%191K | 262.66%257K |
| -Change in payables and accrued expense | 111.19%1.21M | 127.43%626K | 64.94%-386K | 111.69%115K | 185.75%325K | 214.29%572K | -160.80%-2.28M | -3,340.63%-1.1M | -234.24%-984K | 70.51%-379K |
| -Change in other current liabilities | -126.77%-288K | 182.14%469K | 772.50%807K | 13.82%-106K | 27.59%-105K | 30.60%-127K | -4.20%-571K | -650.00%-120K | 31.67%-123K | 17.61%-145K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -16.99%-2.95M | 30.92%-13.44M | -5.53%-3.57M | 5.98%-3.85M | 33.49%-3.5M | 62.49%-2.52M | 17.80%-19.45M | 31.47%-3.38M | 22.38%-4.1M | 28.97%-5.26M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -107.61%-15K | 0 | -15K | 170.61%197K | 0 | 0 | 6,766.67%200K | |||
| Net PPE purchase and sale | ---- | -107.61%-15K | --0 | ---15K | ---- | ---- | 170.61%197K | --0 | --0 | 6,766.67%200K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---- | -107.61%-15K | --0 | ---15K | ---- | ---- | 170.61%197K | --0 | --0 | 6,766.67%200K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 74.96%1.03M | 276.58%11.6M | -53.32%521K | -120.14%-233K | 1,097.32%10.72M | 764.04%591K | -89.51%3.08M | -61.68%1.12M | 2,992.50%1.16M | 179.98%895K |
| Net issuance payments of debt | 7.54%-233K | 32.11%-797K | 37.93%-234K | 38.36%-233K | 37.60%-78K | 14.29%-252K | 69.68%-1.17M | 14.51%-377K | 14.09%-378K | 95.26%-125K |
| Net common stock issuance | --1.37M | 171.55%11.55M | -49.43%755K | --0 | 958.24%10.79M | --0 | -86.81%4.25M | -52.65%1.49M | --1.54M | -8.93%1.02M |
| Proceeds from stock option exercised by employees | --0 | --843K | --0 | --0 | --0 | --843K | --0 | --0 | --0 | --0 |
| Net other financing activities | ---100K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 74.96%1.03M | 276.58%11.6M | -53.32%521K | -120.14%-233K | 1,097.32%10.72M | 764.04%591K | -89.51%3.08M | -61.68%1.12M | 2,992.50%1.16M | 179.98%895K |
| Net cash flow | ||||||||||
| Beginning cash position | -29.36%4.47M | -71.89%6.33M | -12.51%7.52M | 0.74%11.62M | -71.98%4.4M | -71.89%6.33M | 31.71%22.5M | -65.22%8.59M | -61.71%11.53M | -59.39%15.7M |
| Current changes in cash | 0.78%-1.91M | 88.52%-1.86M | -34.54%-3.05M | -39.43%-4.1M | 273.41%7.22M | 71.68%-1.93M | -398.56%-16.18M | -3.24%-2.26M | 45.76%-2.94M | 51.17%-4.16M |
| End cash Position | -41.88%2.56M | -29.36%4.47M | -29.36%4.47M | -12.51%7.52M | 0.74%11.62M | -71.98%4.4M | -71.89%6.33M | -71.89%6.33M | -65.22%8.59M | -61.71%11.53M |
| Free cash flow | -16.99%-2.95M | 30.89%-13.45M | -5.53%-3.57M | 5.61%-3.87M | 33.62%-3.5M | 62.50%-2.52M | 18.70%-19.47M | 33.79%-3.38M | 23.87%-4.1M | 28.87%-5.27M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
